All News

Stigma perpetuated in a health care setting has been linked to greater odds of poor outcomes in the HIV continuum of care for antiretroviral treatment adherence and reduced viral suppression among persons living with HIV in Florida.

Recent CDC data show that a record number of drug overdose deaths occurred in the United States last year, following a dip in 2018. To help improve access to and ease utilization of recovery support systems, Shatterproof, a nonprofit organization committed to reversing the addiction crisis, today launched an Addiction Treatment Locator, Assessment, and Standards Platform (ATLAS).

Increases in different aspects of snoring, such as frequency and loudness, among patients with obstructive sleep apnea and established cardiovascular disease were associated with greater risks of cerebral but not cardiac events, according to study findings.

The National Institutes of Health's (NIH) “All of Us” research project was spotlighted for its potential to explain racial disparities due to coronavirus disease 2019 (COVID-19); the FDA has told Cool Clouds Distribution to stop selling its fruite-flavored e-cigarettes (e-cigs); the American Society of Clinical Oncology (ASCO) and Association of Community Cancer Centers (ACCC) partner to promote minority participation in cancer treatment trials.

Children with type 1 diabetes (T1D) have a less desirable gut microbiome composition, potentially contributing to the development of the disease, according to new research published in the Journal of Clinical Endocrinology & Metabolism.

Two experimental vaccines, one from AstraZeneca and the other from CanSino Biologics, have shown promising results against coronavirus disease 2019 (COVID-19) in a phase 1/2 trial and a phase 2 trial. Results for both were published in The Lancet.

The next several years could bear witness to thousands of additional deaths from cancer that could have been prevented through routine diagnostic care that was delayed because of the coronavirus disease 2019 (COVID-19) pandemic, according to a pair of studies in The Lancet Oncology.

The attorneys general who spoke about the suit—California’s Xavier Becerra, Massachusetts’ Maura Healey, and New York’s Leticia James—said they found it difficult to believe that the administration would adopt the rule in the midst of the coronavirus disease 2019, which is disproportionately affecting communities of color.

Epimacular brachytherapy does not reduce the number of ranibizumab injections required by patients with chronic, active neovascular age-related macular degeneration (ARMD), and it is associated with worse visual acuity compared with anti-vascular endothelial growth factor (VEGF) treatment alone, according to a study published in JAMA Ophthalmology.

By delivering helpful information and fostering online communities, social media may provide rehabilitation and psychological benefits for patients with multiple sclerosis (MS) who have depression, according to the results of a recent Iranian study.

Before coming to the clinic, they had been treated conservatively by primary care physicians and had suffered from pain anywhere from 2 to 40 years.

The company said FDA has set a date of January 20, 2021, for action under the Prescription Drug User Fee Act.

US cancer researchers benefit from the exchange of information with the World Health Organization (WHO), which helps domestic patients as well as international ones.

A recent review discussed how to manage comorbid cardiovascular disease in patients with chronic obstructive pulmonary disease (COPD).

A new study suggests patients with multiple sclerosis (MS) will see their ability to walk decline more rapidly than their hand function.

Older patients with chronic lymphocytic leukemia (CLL) appear to be more likely to have severe symptoms if they contract coronavirus disease 2019, according to new research.

Only about one-third of patients with multiple myeloma who experience a very good partial response to therapy following first relapse, according to a new study.

Psoriatic arthritis and psoriasis have high economic burdens and the total annual costs were similar between the 2 diseases, but the combination of both yielded the highest costs, according to an abstract published at the European League Against Rheumatism annual meeting.

Even in individuals who don't have diabetes, hyperglycemia is an independent risk factor for COVID-19 mortality after 28 days of hospitalization, according to a study published in Diabetolgia.

A recent review explored the mechanism of a 5-hydroxytryptamine (5-HT 1f) agonist used in the treatment of acute migraine pain.

While minimal residual disease has become an important way to track how patients respond to therapies for multiple myeloma, the treatment implications of the metric are not yet clear, according to a review article.

A new analysis of nearly 3 decades of data suggests leukemia rates are falling, except for 2 specific types.

The designation would be to reduce the risk of heart failure or cardiovascular death in patients who have suffered an acute MI, which is a known cause of heart failure.

Patients with Parkinson disease who experience visual impairment were found to be more prone to behavioral issues such as depression and anxiety, as well as dementia and death, according to study findings.

Because male breast cancer is such a rare disease, few strides have been made that convey advantages in its detection, incidence, and mortality. Most treatment guidelines have been extracted from studies performed among female patients.

Hemophilia care principles have been on the rise in Europe over the course of the last decade, however, differing regions and policies on the continent reveal gaps in access to various treatments and specialty services.

Automatic positive airway pressure was found to significantly improve peak oxygen uptake, left ventricular function, and quality of life in patients with comorbid obstructive sleep apnea and heart failure with reduced left ventricular ejection fraction, according to study findings.

Using composite endpoints to predict clinically important deterioration in chronic obstructive pulmonary disease (COPD) could help investigators assess disease activity in clinical trials and better manage individual patients, according to a recent study.